Twenty-five percent of diabetes-related vision loss stems from complications of proliferative
diabetic retinopathy (PDR). Panretinal photocoagulation has been the preferred treatment of …

Background Postoperative vitreous cavity haemorrhage (POVCH) is a significant
complication following vitrectomy for proliferative diabetic retinopathy (PDR). It delays visual …

Aims To examine possible benefits of intravitreal bevacizumab (IVB) pretreatment in
vitrectomy for severe diabetic retinopathy. Methods A comprehensive literature search was …

Background The purpose of this study is to evaluate the role, the safety and the effectiveness
of intravitreal bevacizumab (IVB) injections as an adjunct to vitrectomy in the management of …

The late complications of proliferative diabetic retinopathy (PDR) comprise vitreous
haemorrhage, tractional retinal detachment, combined tractional–rhegmatogenous retinal …

Proliferative diabetic retinopathy (PDR) is the most common cause of severe visual loss in
people with diabetes. Although panretinal photocoagulation (PRP) remains the gold …

Purpose To evaluate the functional and structural outcomes as well as postoperative
complications after pars plana vitrectomy (PPV) for severe features of proliferative diabetic …

Tractional retinal detachment is an end-stage form of diabetic retinopathy that occurs when
contractile forces in the vitreous and neovascular tissue lead to the detachment of the …

Purpose To evaluate costs and cost-utility of early vitrectomy (pars plana vitrectomy [PPV])
compared with panretinal photocoagulation (PRP) and intravitreal ranibizumab (IVR) for …

Purpose: To provide the clinical recommendations for the administration of intravitreal anti-
vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular …